Ranbaxy Pharmaceuticals (RPI), a wholly owned subsidiary of Ranbaxy Laboratories, has introduced the authorized generic cevimeline hydrochloride 30mg capsules in the US. Cevimeline hydrochloride is indicated for the treatment of dry mouth ...
Tags: Generic Evoxac, cevimeline hydrochloride, moisture-producing glands
Daiichi Sankyo Mexico, a subsidiary of Daiichi Sankyo Company, has introduced antihypertensive franchise olmesartan medoxomil in Mexico under the name, Openvas. The company has also unveiled Openvas Co, a combination preparation for use ...
Tags: antihypertensive franchise olmesartan medoxomil, pharmaceuticals
Daiichi Sankyo has signed an exclusive agreement with Coherus BioSciences to develop and commercialize biosimilar candidates in certain Asian countries including Japan. The collaboration will focus on the development, manufacturing and ...
Tags: Daiichi Sankyo, Coherus BioSciences, biosimilar candidates
ArQule and Daiichi Sankyo have signed a special protocol assessment (SPA) agreement with the FDA for Phase 3 trial of Tivantinib in hepatocellular carcinoma (HCC). The SPA process enables FDA to offer official evaluation and written ...
Tags: ArQule, Daiichi Sankyo, SPA, FDA